Thromboelastometry for the assessment of coagulation abnormalities in early and established adult sepsis: a prospective cohort study

被引:103
作者
Daudel, Fritz [1 ,2 ]
Kessler, Ulf [3 ]
Folly, Helene [1 ,2 ]
Lienert, Jasmin S. [1 ,2 ]
Takala, Jukka [1 ,2 ]
Jakob, Stephan M. [1 ,2 ]
机构
[1] Univ Hosp Bern, Dept Intens Care Med, Inselspital, CH-3010 Bern, Switzerland
[2] Univ Bern, CH-3010 Bern, Switzerland
[3] Univ Hosp Bern, Dept Pediat Surg, Inselspital, CH-3010 Bern, Switzerland
来源
CRITICAL CARE | 2009年 / 13卷 / 02期
关键词
DISSEMINATED INTRAVASCULAR COAGULATION; MODIFIED THROMBELASTOGRAPHY; ANTITHROMBIN-III; TISSUE FACTOR; PROTEIN-C; ACTIVATION; HYPERCOAGULABILITY; DYSFUNCTION; DIAGNOSIS; THERAPY;
D O I
10.1186/cc7765
中图分类号
R4 [临床医学];
学科分类号
100218 [急诊医学];
摘要
Introduction The inflammatory response to an invading pathogen in sepsis leads to complex alterations in hemostasis by dysregulation of procoagulant and anticoagulant factors. Recent treatment options to correct these abnormalities in patients with sepsis and organ dysfunction have yielded conflicting results. Using thromboelastometry (ROTEM(R)), we assessed the course of hemostatic alterations in patients with sepsis and related these alterations to the severity of organ dysfunction. Methods This prospective cohort study included 30 consecutive critically ill patients with sepsis admitted to a 30-bed multidisciplinary intensive care unit (ICU). Hemostasis was analyzed with routine clotting tests as well as thromboelastometry every 12 hours for the first 48 hours, and at discharge from the ICU. Organ dysfunction was quantified using the Sequential Organ Failure Assessment (SOFA) score. Results Simplified Acute Physiology Score II and SOFA scores at ICU admission were 52 +/- 15 and 9 +/- 4, respectively. During the ICU stay the clotting time decreased from 65 +/- 8 seconds to 57 +/- 5 seconds (P = 0.021) and clot formation time (CFT) from 97 +/- 63 seconds to 63 +/- 31 seconds (P = 0.017), whereas maximal clot firmness (MCF) increased from 62 +/- 11 mm to 67 +/- 9 mm (P = 0.035). Classification by SOFA score revealed that CFT was slower (P = 0.017) and MCF weaker (P = 0.005) in patients with more severe organ failure (SOFA = 10, CFT 125 +/- 76 seconds, and MCF 57 +/- 11 mm) as compared with patients who had lower SOFA scores (SOFA < 10, CFT 69 +/- 27, and MCF 68 +/- 8). Along with increasing coagulation factor activity, the initially increased International Normalized Ratio (INR) and prolonged activated partial thromboplastin time (aPTT) corrected over time. Conclusions Key variables of ROTEM(R) remained within the reference ranges during the phase of critical illness in this cohort of patients with severe sepsis and septic shock without bleeding complications. Improved organ dysfunction upon discharge from the ICU was associated with shortened coagulation time, accelerated clot formation, and increased firmness of the formed blood clot when compared with values on admission. With increased severity of illness, changes of ROTEM(R) variables were more pronounced.
引用
收藏
页数:8
相关论文
共 44 条
[1]
Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis -: A randomized controlled trial [J].
Abraham, E ;
Reinhart, K ;
Opal, S ;
Demeyer, I ;
Doig, C ;
Rodriguez, AL ;
Beale, R ;
Svoboda, P ;
Laterre, PF ;
Simon, S ;
Light, B ;
Spapen, H ;
Stone, J ;
Seibert, A ;
Peckelsen, C ;
De Deyne, C ;
Postier, R ;
Pettilä, V ;
Sprung, CL ;
Artigas, A ;
Percell, SR ;
Shu, V ;
Zwingelstein, C ;
Tobias, J ;
Poole, L ;
Stolzenbach, JC ;
Creasey, AA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (02) :238-247
[2]
Coagulation disorders in liver disease [J].
Amitrano, L ;
Guardascione, MA ;
Brancaccio, V ;
Balzano, A .
SEMINARS IN LIVER DISEASE, 2002, 22 (01) :83-96
[3]
An audit of red cell and blood product use after the institution of thromboelastometry in a cardiac intensive care unit [J].
Anderson, L ;
Quasim, I ;
Soutar, R ;
Steven, M ;
Macfie, A ;
Korte, W .
TRANSFUSION MEDICINE, 2006, 16 (01) :31-39
[4]
RETRACTED: Effects of a new modified, balanced hydroxyethyl starch preparation (Hextend®) on measures of coagulation (Retracted Article) [J].
Boldt, J ;
Haisch, G ;
Suttner, S ;
Kumle, B ;
Schellhaass, A .
BRITISH JOURNAL OF ANAESTHESIA, 2002, 89 (05) :722-728
[5]
Global tests of haemostasis in critically ill patients with severe sepsis syndrome compared to controls [J].
Collins, Peter W. ;
Macchiavello, Luis I. ;
Lewis, Sarah J. ;
Macartney, Nichola J. ;
Saayman, Anton G. ;
Luddington, Roger ;
Baglin, Trevor ;
Findlay, George P. .
BRITISH JOURNAL OF HAEMATOLOGY, 2006, 135 (02) :220-227
[6]
Dynamic evolution of coagulopathy in the first day of severe sepsis: Relationship with mortality and organ failure [J].
Dhainaut, JF ;
Shorr, AF ;
Macias, WL ;
Kollef, MJ ;
Levi, M ;
Reinhart, K ;
Nelson, DR .
CRITICAL CARE MEDICINE, 2005, 33 (02) :341-348
[7]
Treatment effects of drotrecogin alfa (activated) in patients with severe sepsis with or without overt disseminated intravascular coagulation [J].
Dhainaut, JF ;
Yan, SB ;
Joyce, DE ;
Pettilä, V ;
Basson, B ;
Brandt, JT ;
Sundin, DP ;
Levi, M .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2004, 2 (11) :1924-1933
[8]
The role of microvascular thrombosis in sepsis [J].
Dixon, B .
ANAESTHESIA AND INTENSIVE CARE, 2004, 32 (05) :619-629
[9]
Antithrombin III in patients with severe sepsis - A randomized, placebo-controlled, double-blind multicenter trial plus a meta-analysis on all randomized, placebo-controlled, double-blind trials with antithrombin III in severe sepsis [J].
Eisele, B ;
Lamy, M ;
Thijs, LG ;
Keinecke, HO ;
Schuster, HP ;
Matthias, FR ;
Fourrier, F ;
Heinrichs, H ;
Delvos, U .
INTENSIVE CARE MEDICINE, 1998, 24 (07) :663-672
[10]
Dysfunction of endothelial protein C activation in severe meningococcal sepsis. [J].
Faust, SN ;
Levin, M ;
Harrison, OB ;
Goldin, RD ;
Lockhart, MS ;
Kondaveeti, S ;
Laszik, Z ;
Esmon, CT ;
Heyderman, RS .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (06) :408-416